Mammalian adenylyl cyclases have two homologous cytoplasmic domains (C 1 and C 2 ), and both domains are required for the high enzymatic activity. Mutational and genetic analyses of type I and soluble adenylyl cyclases suggest that the C 2 domain is catalytically active and the C 1 domain is not; the role of the C 1 domain is to promote the catalytic activity of the C 2 domain. Two amino acid residues, Asn-1025 and Arg-1029 of type II adenylyl cyclase, are conserved among the C 2 domains, but not among the C 1 domains, of adenylyl cyclases with 12 putative transmembrane helices. Mutations at each amino acid residue alone result in a 30 -100-fold reduction in K cat of adenylyl cyclase. However, the same mutations do not affect the K m for ATP, the half-maximal concentration (EC 50 ) for the C 2 domain of type II adenylyl cyclase to associate with the C 1 domain of type I adenylyl cyclase and achieve maximal enzyme activity, or the EC 50 for forskolin to maximally activate enzyme activity with or without G s␣ . This indicates that the mutations at these two residues do not cause gross structural alteration. Thus, these two conserved amino acid residues appear to be crucial for catalysis, and their absence from the C 1 domains may account for its lack of catalytic activity. Mutations at both amino acid residues together result in a 3,000-fold reduction in K cat of adenylyl cyclase, suggesting that these two residues have additive effects in catalysis. A second site suppressor of the Asn-1025 to Ser mutant protein has been isolated. This suppressor has 17-fold higher activity than the mutant and has a Pro-1015 to Ser mutation.
The activity of mammalian adenylyl cyclase, the enzyme that converts ATP to cAMP, is the key step in modulating intracellular cAMP concentration in response to extracellular stimulation by hormones, neurotransmitters, and odorants. Nine isoforms of mammalian adenylyl cyclases have been cloned to date, and they belong to a rapid expanding cyclase family that includes class III adenylyl cyclases 1 and guanylyl cyclases (1).
All nine isoforms have a similar structure, including two intensely hydrophobic domains (M 1 and M 2 ) and two 40-kDa cytoplasmic domains (C 1 and C 2 ). The two cytoplasmic domains contain sequences (C 1a and C 2a ) that are homologous to each other and to class III adenylyl cyclases and guanylyl cyclases. Each isoform of adenylyl cyclase not only has distinct patterns of tissue expression but also has unique responses to extracellular and intracellular stimuli (1) (2) (3) . In common, each adenylyl cyclase can be activated by the G protein 2 ␣ subunit, designated as G s␣ , and each can be inhibited by certain adenosine analogues (P-site inhibitors). However, there are several subtype-specific regulators, including forskolin, G protein ␤␥ subunits, the ␣ subunit of G i , G o , and G z , Ca 2ϩ ion, Ca 2ϩ -calmodulin, Ca 2ϩ -calcineurin, cAMP-dependent protein kinase, and PKC (for review, see Refs. [1] [2] [3] . Certain ones of these regulators (e.g. ␤␥) can be either stimulatory or inhibitory, depending on the subtype of adenylyl cyclase (4) . When acting concurrently, the effects of regulators can be independent or interdependent (antagonistic or synergistic). The binding sites of adenylyl cyclases for Ca 2ϩ -calmodulin and G protein ␤␥ subunits are in the C 1 and C 2 domains, respectively (5) (6) (7) (8) . The sites for other regulators and the mechanisms by which they modulate activity of adenylyl cyclase remain to be determined.
One key step in studying the mechanisms for the complicated regulation of adenylyl cyclase is to understand the molecular basis of catalysis. The G s␣ -and forskolin-stimulated soluble adenylyl cyclases can be formed either by mixing IC 1 protein (C 1 domain of type I adenylyl cyclase) and IIC 2 protein (C 2 domain of type II adenylyl cyclase) in vitro or by covalent linkage of IC 1 and IIC 2 proteins (IC 1 IIC 2 ) (9 -12) . From the genetic and biochemical analysis of this soluble adenylyl cyclase and mutational analysis of type I enzyme, we have shown that both C 1 and C 2 domains are required for the high enzymatic activity (13) . Furthermore, the data suggests that the C 2 domain is the catalytic domain while the C 1 domain enhances the activity of the C 2 domain. In this paper, genetic and bio-* This work was supported by National Institutes of Health Grant GM53459, the Cancer Research Foundation, and the Brain Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Dept. of Pharmacological and Physiological Sciences, University of Chicago, 947 E. 58th St. Chicago, IL 60637. 1 Three classes of adenylyl cyclases have been cloned based on the conservation of their catalytic domains: class I, adenylyl cyclases from Enterobacteria including E. coli; class II, toxin-adenylyl cyclases including calmodulin activated toxins from Bordetella pertussis and Bacillus anthracis; and class III, adenylyl cyclases homologous from bacteria to human (1) . Class III adenylyl cyclases have four distinct molecular designs. First are the integral membrane proteins that contain two hydrophobic stretches (ϳ20 kDa each), each consisting of six putative transmembrane helices and two homologous cytoplasmic domains (C 1 and C 2 domains, 30 -40 kDa each). This design includes nine mammalian adenylyl cyclases (type I to type IX), fruit fly rutabaga (Dm rutabaga), and slime mold (Dd ACA) (22, 23, (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . Second are the integral membrane proteins that have one transmembrane helix. This class is found in the parasites, Trypanosoma brucei (Tb ESAG, expression site-associated gene), and Leishmania donovani (Ld-RAC, receptoradenylyl cyclase), and in the slime mold (Dictyostelium discoideum, Dd ACG) (23) (24) (25) . Third are the peripheral membrane proteins from yeast (Schizosaccharomyces pombe, Saccharomyces cerevisiae, and Saccharomyces klyuyveri) (26 -28) . Fourth are the soluble enzymes from the bacteria, Brevibacterium liquefaciens (Bl AC) and Rhizobium meliloti (Rm AC) (29, 30) . 2 The abbreviations used are: G protein, guanine nucleotide binding regulatory protein; G s␣ , the ␣ subunit of the G protein that stimulates adenylyl cyclase; Fsk, forskolin; IC 1 protein, C 1 domain of type I adenylyl cyclase; IIC 2 protein, C 2 domain of type II adenylyl cyclase; GTP␥S, guanosine-5Ј-[␥-thio]triphosphate; aa, amino acid(s); 2Ј-D-3Ј-AMP, 2Јde-oxyadenosine 3Ј-monophosphate; kbp, kilobase pair; IPTG, isopropyl-1-thio-␤-D-galactopyranoside; LB, Luria broth; CMV, cytomegalovirus; IBMX, isobutylmethylxanthine. chemical analyses are used to identify two amino acid residues, asparagine and arginine that are crucial for catalysis and might play an important role in inactivating the enzymatic activity of the C 1 domain.
EXPERIMENTAL PROCEDURES
Materials-Forskolin was from Calbiochem (La Jolla, CA); 2Ј-d-3Ј-AMP was from Sigma; restriction enzymes and Vent DNA polymerase were from New England Biolabs (Beverly, MA); Bradford reagent was from Bio-Rad; ECL system was from Amersham Corp.; Ni-NTA resin was from Qiagen (Chatsworth, CA); and Escherichia coli XL1-red cells were from Stratagene (La Jolla, CA). GTP␥S was purchased from Pharmacia Biotech Inc. and purified by FPLC Mono Q column chromatography.
Isolation 3 malT/malT 3 ) was constructed so that cAMP synthesis by the cloned cyclase replaced such synthesis by the bacteria gene and that made it possible to enrich for mutations that decreased synthesis of cAMP. To construct E. coli WJT-1 cells, E. coli TK2313 (F -thi rha lacZ nagA ⌬(kdpAE81) trk1 trkA405 endoA) was transduced with P1 lysate of a thr34::Tn10 strain, and a tetracycline-resistant colony was purified. This strain was then transduced to Thr ϩ , araD139 with a lysate of strain MC4100 (14) . One araD139 derivative of TK2313 was purified and transduced to ilv500::Tn10 with a lysate of strain MRi134 (pertinent marker is ilv500::Tn10), and a tetracycline-resistent colony was purified. The resulting strain was transduced to ilv ϩ , ⌬cya with a lysate of strain TK2648 (pertinent marker ⌬(cya)8306, a deletion originally obtained from J. Beckwith (Harvard Medical School) in strain CA8306), and a ⌬cya transductant was purified. Finally, the F141 plasmid that carried the crp malT TrkA genes was introduced by selection for growth on medium containing 0.1 mM K ϩ (15). Two conditions were used to select the loss of function IC 1 IIC 2 mutants in which expression of cAMP-dependent genes was growth inhibitory or lethal. The first was the sensitivity of E. coli to infection and killing by phage, and the second was its inhibition of growth by a metabolic intermediate of arabinose catabolism. A library of plasmids that had mutations at the coding region of IC 1 IIC 2 was constructed by propagating plasmid pProEx-HAH6-IC 1 4 The resulting DNAs were digested with EcoRI and HindIII and ligated into pProEx-HAH6 that had been digested with the same enzymes. The resulting constructs were confirmed by dideoxy nucleotide sequencing. Kunkle's method (17) was used to incorporate the desired point mutations into the phagemid vectors, pProEx-HAH6-IIC 2 and pProEx-HAH6-IIC 2 -M16 (N1025S). Oligonucleotides (23-mer) used for mutagenesis contained 10 complementary nucleotides flanking each side of the target codon, which was replaced with the appropriate codon for the mutants that had single point mutation (N1025S, N1025A, N1025D, N1025K, N1025Q, N1025T, and R1029A) or double point mutations (IIC 2 -P1015S, N1025S; P1015A,N1025S; P1015D,N1025S; P1015E,N1025S; P1015N,N1025S; and P1015Q,N1025S). Mutations were confirmed by dideoxy nucleotide sequencing of the plasmid DNA.
To construct pRC/CMV-ACII N1025K, the 0.7-kbp DNA was isolated from pProEx-HAH6-IIC 2 -N1025K that was digested with restriction enzymes, BspEI and XbaI, and cloned into pSK-ACII that had been digested with the same enzymes. The resulting plasmid was then digested with HindIII and XbaI, and the 3.3-kbp DNA, which encoded type II adenylyl cyclase, was excised and ligated to pRC/CMV that had been digested with HindIII and XbaI. The same approach was used to construct pRC/CMV-ACII for expression of type II adenylyl cyclase. 2 -The plasmids that encoded wild type or mutant forms of IIC 2 were transformed into E. coli BL21(DE3) cells. E. coli that harbored the desired plasmid were cultured in LB medium containing 50 mg/ml ampicillin at 30°C. When A 600 reached 0.4, IPTG (100 M) was added. After 3-4 h, the induced cells were then collected and lysed, and IIC 2 proteins were purified using the Ni-NTA column and FPLC Q-Sepharose column as described (9) . The Coomassie Blue staining of SDSpolyacrylamide gel electrophoresis was used to determine the protein peak in the fractions from the Q-Sepharose column. The concentration of proteins was determined using Bradford reagent and bovine serum albumin as standard (18) .
Expression and Purification of Wild Type and Mutant Forms of IIC

Expression of ACII-N1025K in HEK 293 (ATCC CRL1573) and Mouse Adrenal Y1-Mouse adrenal Y1-t4 cells (kindly provided by
Dr. E. Simpson, Univ. of Texas Southwestern Medical School) were selected for their high sensitivity to morphological changes upon cAMP stimulation. HEK 293 and mouse adrenal Y1-t4 cells (10 6 /60-mm dish) were transfected with pRC/CMV, PRC/CMV-ACII, or pRC/CMV-ACII-N1025K by lipofection (Life Technologies, Inc). Geneticin (0.5 mg/ml) was used to select HEK 293 and mouse adrenal Y1-t4 cells that had stably incorporated the expression constructs, and cell colonies surviving antibiotic selection from a single transfection were pooled into a polyclonal population for subsequent analysis.
Adenylyl Cyclase Assay-Activities of the soluble adenylyl cyclases were assayed for 20 min at 30°C in the presence of 10 mM MgCl 2 (19) . Wild-type IIC 2 and IIC 2 mutant proteins were premixed with IC 1 on ice for 10 min before the assay. Recombinant G s␣ was purified and activated by GTP␥S as described (20, 21) . Plasma membranes from the pools of HEK 293 and mouse adrenal Y1-t4 stable transformants were isolated as described (22) . Enzyme activity of the membrane fractions was assayed for 30 min at 30°C in the presence of 30 M AlCl 3 , 10 mM MgCl 2 , and 10 mM NaF (AMF) or 100 M forskolin (Fsk).
RESULTS
Isolation and Analysis of Loss of Function IC 1 IIC 2 Mutants-
We have shown that coexpression of IC 1 IIC 2 and constitutively active G s␣ , G s␣ Q227L can complement the genetic defects of E. coli ⌬cya, which has a deletion of the adenylyl cyclase gene and thus fails to synthesize cAMP (10) . To select IC 1 IIC 2 mutants that have reduced adenylyl cyclase activity (loss of function mutants), we have constructed an E. coli strain, WJT-1 (⌬cya AraD -endoA crp/crp 3 malT/malT 3 ). Two conditions were used to select the loss of function IC 1 IIC 2 mutants in which expression of cAMP-dependent genes was growth inhibitory or lethal. The first was the sensitivity of E. coli to infection by phage. A virulent mutant of bacteriophage (vir) kills E. coli. Absorption of to the cell begins with binding to the LamB protein. Expression of LamB protein is induced when E. coli is grown with medium containing maltose, and expression of the LamB is dependent on cAMP. Thus, strains that express the maltose genes are killed by vir. Mutants that do not express a functional LamB protein do not absorb phage and thus survive. Therefore, selection for resistance to vir enriches for mutants unable to make cAMP. As expected, most of WJT-1 cells (Ͼ99.9%) that expressed both IC 1 IIC 2 and G s␣ Q227L were sensitive to infection by vir (plaques were opaque), while those that expressed IC 1 IIC 2 or G s␣ Q227L alone were insensitive to infection (data not shown).
The second condition for selection of loss of function mutants was the growth inhibition of E. coli by a metabolic intermediate of arabinose catabolism. Arabinose induces the enzymes specific to early steps of arabinose catabolism. When ribulose-1-phosphate epimerase is defective, the product produced by the araD gene, ribulose-1-phosphate, accumulates in the cell. This sugar phosphate, like many others, is growth inhibitory when accumulated to high levels. Since expression of the genes for arabinose catabolism is also dependent on cAMP, araD mutants that make cAMP are inhibited by arabinose, while those that do not make cAMP are not. E. coli WJT-1 strain was AraD Ϫ , and thus 90% of WJT-1 cells that expressed IC 1 IIC 2 and G s␣ Q227L were growth-arrested when arabinose was added (both in minimal and complex media). As a control, arabinose had no effect on the growth of WJT-1 cells that expressed either IC 1 IIC 2 or G s␣ Q227L alone. The combination of selection by vir and arabinose provided 10 4 -fold enrichment of WTJ-1 cells that failed to produce high concentrations of intracellular cAMP (Fig. 1A) .
The first step in selecting IC 1 IIC 2 mutants that failed to be activated by G s␣ Q227L in vivo was random mutagenesis of the plasmid containing the coding region of IC 1 IIC 2 by growth in mutator strain XL-1 red (mutT mutD mutS). This strain can introduce a variety of mutations, including transitions, transversions, and frameshifts. The cells that failed to produce cAMP were selected based on their insensitivity to infection by vir and to growth inhibition by arabinose. Approximately 20-fold higher numbers of colonies of WJT-1 cells that carried the mutagenized plasmids (pProEx-HAH6-IC 1 IIC 2 ) were observed than those that carried the unmutagenized pProEx-HAH6-IC 1 IIC 2 , indicating that this selection did enrich for the loss of function mutants.
Thirty clones were selected for analysis. The coding regions for IC 1 IIC 2 of 30 colonies were introduced back to unmutated pProEx-HAH6, and they were analyzed genetically (phenotype on maltose-MacConkey medium) and biochemically (immunoblot and adenylyl cyclase activity). Two IC 1 IIC 2 mutants (M8 and M16) were of interest. WJT-1 cells that carried either IC 1 IIC 2 -M8 or M16 were insensitive to infection by vir and growth arrest by arabinose and were delayed in being positive on maltose-MacConkey medium (Fig. 1A) . Lysates from BL21(DE3) cells that expressed IC 1 IIC 2 -M8 and M16 mutants had normal expression of 60 kDa IC 1 IIC 2 , but they had a significant reduction (4-and 95-fold, respectively) in G s␣ -and forskolin-stimulated adenylyl cyclase activity (Fig. 1, A and B) . IC 1 IIC 2 -M8 had a relatively conserved leucine to phenylalanine change at aa 362 of type I adenylyl cyclase (CTC3 TTC) (Fig. 2) . IC 1 IIC 2 -M16 has two transitions, resulting in the change of a highly conserved asparagine to serine at aa 1025 (AAC3 AGC) and a silent mutation at aa 832 (TTG3 TTA) of type II adenylyl cyclase (Fig. 2) .
Three IC 1 IIC 2 mutants had 2-5-fold reduction in expression of 60 kDa proteins that were correlated well with reduced adenylyl cyclase activity (data not shown). Immunoblot showed that all three mutants had increased amounts of smaller molecular weight immunoreactive bands, suggesting that the reduced protein expression was associated with increased proteolysis (not shown). Sequence analysis of one of these mutants (M25) showed that IC 1 IIC 2 -M25 had a glutamine to lysine change at aa 848 of type II adenylyl cyclase (GAG3 AAG). We have shown that the region from aa 821 to aa 855 of type II adenylyl cyclase is not required for catalysis (9) . Therefore, the mutation at aa 848 is likely to cause a structural change that renders IC 1 IIC 2 highly susceptible to proteolysis. Although WJT-1 cells that carried the plasmids for the remaining 25 IC 1 IIC 2 mutants did take longer to be positive on maltoseMacConkey, E. coli lysates of these mutants did not have a significant reduction in enzyme activity. Thus, they were not analyzed further.
Characterization of the IIC 2 -N1025 and R1029A MutantsGenetic and mutational analyses suggest that the C 2 domain of mammalian adenylyl cyclase is the catalytic domain, and the C 1 domain is not (10, 13) . This begs the questions as to which amino acids are crucial for catalytic activity of the C 2 domains, and are they absent at the C 1 domains? More than 30 different adenylyl cyclases and guanylyl cyclases share the common homologous cytoplasmic domains, designated as the cyclase domains (1) . For the functional enzyme, the cyclase domains can work as the homo-oligomer, such as adenylyl cyclases from yeast, Trypanosome, Dictyostelium (ACG), Leishmania, Brevibacterium, and Rhizobium (23) (24) (25) (26) (27) (28) (29) (30) . The cyclase domains can also exist as an obligatory heterodimer for enzymatic activity such as the C 1 and C 2 domains from type I to type IX adenylyl cyclases, Drosophila rutabaga, and Dictyostelium ACA, and the ␣ and ␤ subunits of soluble guanylyl cyclases (22, 23, (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) . The amino acid residues that are crucial for catalysis should be conserved among all the cyclase domains that function by themselves and among one of the two cyclase domains among the obligatory hetero-dimers. Two amino acid residues (Asn-1025 and Arg-1029 of type II adenylyl cyclase) fits this criterion (Fig. 2, letter b) . They are conserved among all of the cyclase domains that function by themselves. They are also conserved among the catalytic C 2 domain of adenylyl cyclases and the ␤ subunits of guanylyl cyclases but are not conserved in the C 1 domain of adenylyl cyclases or the ␣ subunit of soluble guanylyl cyclases. We thus examined the effects of mutations at Asn-1025 and Arg-1029 on enzyme activity of IC 1 ϩIIC 2 complex.
To evaluate the effects of mutations of Asn-1025 of type II adenylyl cyclase, we constructed and purified IIC 2 mutant proteins that had the Asn-1025 changed to Thr, Ser, Ala, Gln, Asp, and Lys (IIC 2 -N1025T, N1025S, N1025A, N1025Q, N1025D, and N1025K). All six mutants expressed normal amounts of enzyme compared with wild-type IIC 2 based on immunoblot of E. coli BL21(DE3) lysates (Fig. 3) . They also could be purified readily (Fig. 3) . The biochemical properties of these IIC 2 -N1025 mutants are summarized in Table I and Fig. 4 . All the enzyme assays were performed in the presence of a fixed amount of IC 1 . Mutations of Asn-1025 caused a range of reduction (10 -5000-fold) in forskolin-and G s␣ -activated adenylyl cyclase activity (K cat ) with the order of N1025T, N1025S, N1025A, N1025Q, N1025D, and N1025K from the highest enzyme activity to the lowest. IIC 2 -N1025T and IIC 2 -N1025S had similar values of K m for ATP and of half-maximal concentration (EC 50 ) for forskolin stimulation in the presence of GTP␥S-G s␣ compared with wild-type IIC 2 . In addition, similar values were observed in EC 50 for wild-type IIC 2 and IIC 2 mutants (N1025T and N1025S) to form complexes with IC 1 and reach maximal enzyme activity that was stimulated by either forskolin alone or forskolin plus GTP␥S-G s␣ . Although the enzyme activity of mutants IIC 2 -N1025A, N1025Q, N1025D, and N1025K was too low to determine K m values of ATP and EC 50 values for forskolin stimulation and for IIC 2 requirement, all four mutant proteins could effectively compete with wild-type IIC 2 to form a complex with IC 1 and block wild-type IIC 2 enzyme activity (Fig.  4D) . The concentrations of IIC 2 mutants required to achieve half-maximal inhibition (IC 50 ) were close to the concentration of wild-type IIC 2 protein in the assays (0.26 M). This result indicated that the mutation of Asn-1025 caused reduction in catalysis without gross structural alteration. Both IIC 2 mutants (N1025T and N1025S) had reduced sensitivity to 2Ј-d-3Ј-AMP, an inhibitor of adenylyl cyclase activity, when both forskolin and GTP␥S-G s␣ were present (Fig. 3C and Table I) .
We then examined the effects of the mutation from arginine to alanine at aa 1029 (IIC 2 -R1029A). IIC 2 -R1029A could be expressed normally and was readily purified to homogeneity (Fig. 3) . The biochemical properties of IIC 2 -R1029A are similar to IIC 2 -N1025S (Table I and Fig. 4 ). When mixed with IC 1 , IIC 2 -R1029A had 30-fold reduction in catalysis compared with wild-type IIC 2 . Similar values to that of wild-type IIC 2 were observed in K m of ATP, EC 50 for forskolin to maximally activate the complex of IC 1 and IIC 2 -R1029A, and EC 50 for IIC 2 -R1029A to form a complex with IC 1 for reaching maximal activation (Table I and Fig. 4) . The IC 50 value of 2Ј-d-3Ј-AMP for IIC 2 -R1029A was about 200-fold higher than that of wild-type IIC 2 . A similar mutation in recombinant type I adenylyl cyclase was analyzed and this mutation also had reduced catalysis without altered ability of the mutant protein to interact with GTP␥S-G s␣ (13) .
We also examined the effects of combined mutations at both arginine 1029 to alanine and asparagine 1025 to serine (IIC 2 -N1025S,R1029A). IIC 2 -N1025S,R1029A could be expressed and purified similar to wild-type IIC 2 (Fig. 3) . It had 3,000-fold reduction in activity compared with wild-type IIC 2 (Table I) . When mixed with wild-type IC 1 and IIC 2 proteins, IIC 2 -FIG. 2. Sequence comparison of adenylyl cyclases and guanylyl cyclases at the two highly conserved regions, A and B. Diagram (top) shows the relationship of regions A and B, which are connected by a highly variable region (dotted line). The consensus sequences (bottom) were obtained using the cyclase domains from closely related family of cyclases (three to ten types of cyclases), and those consensus sequences were then used to compare among the distally related families of cyclases. Sequences in bold are absolutely conserved within the family of the indicated groups of cyclases, and sequences underlined are conserved among nine out of ten adenylyl cyclases. The mutations at the IC 1 IIC 2 mutants, M8 and M16, and IIC 2 mutants, R1029A and P1015S,N1025S are shown. The letters at the tops of the sequences mean absolutely conserved glycine (a), Asn-1025 and Arg-1029 that are conserved among all adenylyl and guanylyl cyclases except those of the C 1 domain of adenylyl cyclases with 12 transmembrane helices and the ␣ subunits of soluble guanylyl cyclases (b), aspartate that is conserved among all cyclases except those of the C 2 domain of adenylyl cyclases with 12 transmembrane helices and is crucial for enzyme activity (c) (13) , mutation at these residues results increase of K m for ATP (d) (13) , and mutation at the fly learning mutant, D. rutabaga (e) (42) N1025S,R1029A was a potent inhibitor for enzyme activity, indicating that it interacted with IC 1 normally. Together, this result indicates that both Asn-1025 and Arg-1029 are crucial for catalysis, and the effect of mutations on catalysis by these two residues is additive.
Effect of Asparagine Mutation at aa 1025 on Type II Adenylyl Cyclase-To evaluate the effect of Asn-1025 on full-length type II adenylyl cyclase, we constructed expression vectors with the cytomegalovirus (CMV) promoter that carried cDNA for type II adenylyl cyclase with or without the N1025K mutation. HEK 293 and mouse adrenal Y1-t4 cells were transfected with the expression vectors, and 50 -200 colonies of stable transformants were pooled together and analyzed for their adenylyl cyclase activity (Fig. 5) . As expected, plasma membranes from HEK 293 and mouse adrenal Y1-t4 cells that had stably integrated the vector with type II adenylyl cyclase had 2-8-fold increases in adenylyl cyclase activity over cells that had integrated the control vector. When stimulated by forskolin, plasma membranes from HEK 293 and mouse adrenal Y1-t4 cells that had integrated the vector with type II adenylyl cyclase containing the N1025K mutation not only did not have increased enzyme activity but had a 25-50% reduction in enzyme activity compared with that from the control cells. This indicates that type II adenylyl cyclase containing the N1025K mutation is catalytically inactive and can dominantly block the activation of endogenous adenylyl cyclases. The mechanism for such blocking is currently under investigation.
Selection and Analysis of the Second Site Suppressor of the IC 1 IIC 2 -N1025S-Cyclic nucleotide phosphodiesterase hydrolyzes cAMP, and thus a defect in the cpdB gene enhances accumulation of intracellular cAMP. Therefore, an E. coli strain, WJT-3 (⌬cya CpdB -), was constructed to increase the sensitivity of our genetic screen. As expected, E. coli WJT-3 cells can grow on maltose-minimal medium with 10-fold less b The K m values were determined using ATP concentrations ranging from 0.06 to 2 mM with 2-fold dilution and calculated from a least square fit of the enzyme activity to a simple rectangular hyperbola. The means Ϯ S.E. are the averages of at least two experiments. cAMP than is required by E. coli ⌬cya, CpdB ϩ . When harboring plasmids for expression of G s␣ Q227L and IC 1 IIC 2 , E. coli WJT-3 cells can grow about twice as fast (2 days) on maltoseminimal medium than E. coli ⌬cya, CpdB ϩ (4 days). We employed the second site suppressor approach to search for amino acid residues that can suppress the catalytic defect of IC 1 IIC 2 -N1025S. A library of randomly mutated plasmids that encoded IC 1 IIC 2 -M16 was generated by passing through E. coli XL-1 red cells and then transformed to E. coli WJT-3 cells that expressed G s␣ -Q227L. More than 200 colonies that carried mutated IC 1 IIC 2 -M16 and G s␣ -Q227L were grown within 3 days, similar to those that carried wild-type IC 1 IIC 2 and G s␣ -Q227L. Eight independent clones that had different colony sizes were selected to further analyze. All eight IC 1 IIC 2 revertants had similar adenylyl cyclase activity and time required for being positive on maltose-MacConkey, as did wild-type IC 1 IIC 2 . Sequence analysis revealed that all of them had a transition to revert serine back to asparagine at aa 1025. This result indicates again that asparagine at aa 1025 is crucial for the enzyme activity of adenylyl cyclase.
To avoid the true revertants in the genetic screen, we constructed pProExHAH6-IC 1 IIC 2 -N1025S(TCG) which had the TCG as codon for serine at aa 1025. In this plasmid, three mutational events are required to revert the TCG codon to the codon for asparagine (AAC/T). A library of randomly mutated pProEx-HAH6-IC 1 IIC 2 (TCG) plasmids was generated by passage through E. coli XL1 red cells and was used to select the revertants as described above. As expected, E. coli WJT-3 cells that expressed IC1IIC2-N1025S and G s␣ Q227L were negative on maltose-minimal medium and were not positive on maltoseMacConkey plates (Fig. 6) . When coexpressed with G s␣ -Q227L in E. coli WJT-3 cells, two independent IC 1 IIC 2 revertants allowed E. coli to grow in 4 days on maltose-minimal medium and were positive within 44 h on maltose-MacConkey plates, significantly better than the IC 1 IIC 2 mutant but not as well as wild-type IC 1 IIC 2 (Fig. 6A) (Fig. 6A) . DNA sequencing analysis revealed that both revertants retained the TCG codon at aa 1025 but had acquired a proline to serine at aa 1015 (CCA3 TCA) of type II adenylyl cyclase.
Characterization of IIC 2 -P1015,N1025S) Mutations-To evaluate the effect of proline mutation at aa 1015 of type II enzyme, we constructed six IIC 2 mutants, all having serine at aa 1025 and a mutation from Pro 1015 to Ser, Ala, Asp, Glu, Asn, or Gln (IIC 2 -P1015S,N1025S; P1015A,N1025S; P1015D,1025S; P1015E,N1025S; P1015N,N1025S; and P1015Q,N1025S). Based on immunoblot analysis of lysates from E. coli BL21(DE3) cells, IIC 2 -P1015S,N1025S, IIC 2 -P1015A,N1025S, and IIC 2 -P1015E,N1025S were expressed normally, whereas IIC 2 -P1015D,N1025S, IIC 2 -P1015N, N1025S and IIC 2 -P1015Q,N1025S had 50 -90% reductions in expression as the soluble proteins. To characterize these proteins, all were purified to near homogeneity (Fig. 6B) . The biochemical properties of these mutants are summarized in Table II . All six mutants had 3-10-fold higher G s␣ -or forskolinstimulated enzyme activities compared with IIC 2 -N1025S, while their enzyme activities were still significantly lower than wild-type IIC 2 . The IC 50 values for 2Ј-d-3Ј-AMP to inhibit the enzyme activity were slightly reduced compared with IIC 2 -N1025S (particularly IIC 2 -P1015D,N1025S and IIC 2 -P1015N,N1025S) but were still significantly higher than that Lysates from E. coli BL21(DE3) that expressed wild-type IC 1 IIC 2 (WT), IC 1 IIC 2 -N1025S (N1025S), and IC 1 IIC 2 -P1015S,N1025S (P1015S, N1025S) were used for adenylyl cyclase assay in the presence of 100 M forskolin and for immunoblots using a monoclonal antibody, 12CA5. B, purified IIC 2 -P1015,N1025S mutant proteins. IIC 2 mutant proteins were analyzed in the same manner as described in Fig. 3 
DISCUSSION
Mammalian adenylyl cyclase has a complex molecular design, presumably to integrate and respond to various extracellular and intracellular stimuli. Genetic and biochemical analyses of type I and soluble adenylyl cyclases indicate that both the C 1 and C 2 domains are essential for the high enzyme activity and only the C 2 domain is catalytic. 5 In this paper, we have shown that the conserved asparagine and arginine residues are crucial for catalysis, and they might be two of the key residues that prevent the C 1 domain from being catalytically active. 6 The residue in the C 1 domain that corresponds to Asn-1025 of the C 2 domain is commonly a threonine. Interestingly, this replacement of Asn-1025 in the C 2 domain results in the retention of the highest activity of the replacements examined (Fig. 2) . The corresponding residue of the conserved C 2 arginine in the C 1 domain is either histidine or lysine (Fig. 2) . We have shown that the arginine to lysine substitution in type I adenylyl cyclase did not alter the enzyme activity, highlighting the role of the substitution at the corresponding site of the C 2 asparagine in inactivating the enzyme activity of the C 1 domain (13) . The role of the conserved asparagine and arginine in catalysis remains to be determined. One possible role is to coordinate and stabilize the PO 5 transition state similar to the way in which the Gln and Arg are involved in the hydrolysis of GTP in the G protein ␣ subunit (47, 48) . Structural determination of the cyclase domain with its substrate should help to elucidate the roles of these two residues in catalysis.
The changes in free energy (⌬⌬G) have been used to determine whether the two mutations have an additive effect on catalysis (49) . If the free energy change due to the first mutation is denoted by ⌬⌬G x and that due to the second mutation is ⌬⌬G y , the change in free energy observed in the double mutant, ⌬⌬G x,y , can be expressed as ⌬⌬G Thus, it appears that the conserved Asn-1025 and Arg-1029 act independently in the catalytic activity of adenylyl cyclase. How does a proline to serine mutation at aa 1015 increase 10 -15-fold enzyme activity of IIC 2 -N1025S? Proline can exist as either cis-or trans-peptide bonds. However, a charged lysine residue, not Phe, Tyr, or Leu, immediately proceeds proline at aa 1015, making it less likely to be cis-Pro (50) (Fig. 2) . The entropy effect of proline contributes positively in protein stability; thus, mutation at a proline residue might introduce an increased flexibility (50, 51) . We hypothesize that the openclose conformational switch is essential for the catalytic activity of adenylyl cyclase and that the increased flexibility of the protein by the proline to serine mutation might facilitate such a switch (1, 13) . Further experiments are required to test this hypothesis. Proline is involved in numerous gain of function mutants in other proteins. Proline to leucine has been shown to render G protein-coupled ␣-factor receptor to be constitutively active and second site suppressor mutations from other amino acids to proline enhance the functioning of several mutated proteins, i.e. triosephosphate isomerase, F 1 F 0 ATP synthase, and lactose permease (52) (53) (54) (55) .
Three genetic model systems have been set up to study catalysis and regulation of adenylyl cyclases that have 12-transmembrane helices (10, 56 -58) . In both E. coli and Saccharomyces cerevisiae, the paradigm of cAMP-dependent cell growth under certain growth conditions are utilized, while in D. discoideum, that of cAMP-mediated cell aggregation is applied. Conditions that allow selection of mutants that gain or lose cAMP accumulation have been established both in E. coli and in D. discoideum. Mutations that inactivate or increase the basal enzyme activity have been found in ACA and in soluble adenylyl cyclase (56, 57, see above). These systems should 5 We have previously shown that IIC 2 protein had no detectable enzyme activity in the presence of IBMX, phosphodiesterase inhibitor (9) . However, using a high quantity of IIC 2 (100 g) in the absence of IBMX, low but reproducible G s␣ -and forskolin-stimulated enzyme activity was detected (9.1 nmol⅐min Ϫ1 ⅐mg
Ϫ1
; 1000-fold less than the IC 1 ϩ IIC 2 complex) when only IIC 2 protein was present. IBMX may have inhibited the low activity of IIC 2 protein. 6 We have constructed IC 1 mutants that have single or double mutations from Thr-426 and Val-430 (corresponding residues of C 2 Asn-1025 and Arg-1029) to Asn and Arg, respectively. When mixed with wild-type IIC 2 protein, the forskolin-stimulated activities of E. coli lysates containing IC 1 mutants were reduced 10 -50-fold compared with that of wild-type IC 1 . When mixed with mutant forms of IIC 2 proteins (IIC 2-N1025S and IIC 2-R1029A ), the enzyme activity of E. coli lysates containing IC 1 mutants were similar to or less than that of wild-type IC 1 . Thus, IC 1 protein cannot be converted to be catalytically active by changing either Thr-426 to Asn or Val-430 to Arg or by changing both residues simultaneously. permit the genetic analysis of interactions between adenylyl cyclases and its regulators. In addition, these systems should help us to identify the pharmacological reagents that could modulate the enzyme activity of adenylyl cyclase with isoform specificity.
